Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Concerning Microbial Ecosystem Therapeutics 2 (MET-2) & Ulcerative colitis (UC), Microbial Ecosystem Therapeutics 2 (MET-2) is an investigational therapy designed to restore gut microbial balance, currently being evaluated for conditions like ulcerative colitis (UC). There are no published clinical trial results or regulatory approvals from the FDA or EMA specifically linking MET-2 to UC treatment. Literature generally discusses the potential of precision microbiota therapies for managing inflammatory bowel diseases, including UC, but does not specifically mention MET-2 in clinical or regulatory contexts (1, 2).